Related Experiment Video

Updated: Nov 7, 2025

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
09:44

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis

Published on: October 14, 2025

131

Telemedicine and Integrated Multidisciplinary Care for Pediatric IBD Patients: A Review

Lauren M Potthoff1,2

  • 1Division of Gastroenterology, Hepatology and Nutrition, Pritzker Department of Psychiatry and Behavioral Health, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL 60611, USA.

Children (Basel, Switzerland)
|April 30, 2021
PubMed

Insights

The COVID-19 pandemic accelerated telemedicine adoption in pediatric inflammatory bowel disease (IBD) care. This review examines virtual multidisciplinary IBD treatment delivery and future research needs.

Area of Science:

  • Pediatric Gastroenterology
  • Digital Health
  • Healthcare Management

Background:

  • The COVID-19 pandemic necessitated a rapid shift to telemedicine for pediatric inflammatory bowel disease (IBD) care.
  • Telemedicine delivery of integrated multidisciplinary care, the standard for pediatric IBD, requires examination.
  • The long-term role of telemedicine in pediatric IBD remains to be determined.

Purpose of the Study:

  • To review existing literature on telemedicine-delivered integrated multidisciplinary care for pediatric IBD.
  • To present a case study of a pediatric IBD program's transition to telemedicine during the pandemic.
  • To identify challenges and future research directions for telemedicine in pediatric IBD.

Main Methods:

  • Literature review of studies on telemedicine for pediatric IBD.
  • Description of a single integrated multidisciplinary IBD program's adaptation to telemedicine.
  • Discussion of implementation challenges and research gaps.

Main Results:

  • Limited existing literature specifically addresses telemedicine for integrated multidisciplinary pediatric IBD care.
  • The transition to telemedicine presented operational and clinical challenges.
  • The need for further research into effective virtual multidisciplinary care models is highlighted.

Conclusions:

  • Telemedicine offers a viable platform for delivering integrated multidisciplinary care in pediatric IBD, though challenges exist.
  • Further research is crucial to optimize virtual care delivery and ensure equitable access for pediatric IBD patients.
  • Adapting multidisciplinary care models for telemedicine is essential for the future of pediatric IBD management.

Keywords:
inflammatory bowel diseasepediatrictelemedicine

More Related Videos

Guidelines for Elective Pediatric Fiberoptic Intubation11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

17.9K
Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis05:56

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

265

Related Concept Videos

Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
261
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
476
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
491
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
170
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
281
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
394